PHENYTOIN STIMULATES CHONDROGENIC DIFFERENTIATION IN MOUSE CLONAL CHONDROGENIC EC CELLS, ATDC5
スポンサーリンク
概要
- 論文の詳細を見る
Phenytoin (DPH) is known to affect bone formation. However, the mechanism of this effect has not been well understood. In this study, we evaluated the effects of DPH on cartilage formation in a model system using ATDC5 cells, a clonal murine chondrogenic cell line. Alcian blue staining for cartilage nodules and real-time reverse-transcription polymerase chain reaction for the expression of genes encoding type II collagen, aggrecan, transforming growth factor (TGF)-β1, bone morphogenetic protein (BMP)-4, parathyroid hormone-related peptide (PTHrP), indian hedgehog (Ihh), and patched (Ptc) were performed in ATDC5 cells cultured with DPH. The ATDC5 cells demonstrated enhanced cartilage formation in cultures with DPH. During promoted chondrogenic differentiation, it was observed that DPH increased the mRNA expression of TGF-β1, BMP-4, Ihh, and Ptc, in a dose-dependent manner on Days 5 to 15. In contrast, other antiepileptic drugs, phenobarbital and valproic acid had no effects on chondrogenesis in ATDC5 cells and osteogenesis in MC3T3-E1 cells. Our results provide fundamental evidence that DPH has a direct stimulatory effect on cartilage formation by regulating TGF-β and hedgehog signaling molecules, and that DPH effect on bone formation, including chondrogenesis and osteogenesis, is distinct from other antiepileptic drugs as suggested in clinical settings.
- 日本トキシコロジー学会の論文
- 2005-08-29
著者
-
Fujiwara Michio
Safety Research Laboratory, Institute for Drug Development Research, Yamanouchi Pharmaceutical
-
Okada Akinobu
Safety Research Laboratories Institute For Drug Discovery Research Yamanouchi Pharmaceutical Co. Ltd
-
Okada Akinobu
Safety Research Laboratories Yamanouchi Pharmaceutical Co. Ltd.
-
Shiomi Teruaki
Safety Research Laboratories Yamanouchi Pharmaceutical Co. Ltd.
-
Fujiwara Michio
Toxicologic Pathology Drug Safety Res. Laboratories Astellas Pharma Inc.
-
AOKI Yoshinobu
Safety Research Laboratories, Yamanouchi Pharmaceutical Co., Ltd.
-
Fujiwara Michio
Safety Research Laboratories Yamanouchi Pharmaceutical Col Ltd
-
Aoki Yoshinobu
Safety Research Laboratories Yamanouchi Pharmaceutical Co. Ltd.
関連論文
- SEX STEROID HORMONE RECEPTORS IN THE DEVELOPING FEMALE REPRODUCTIVE TRACT OF LABORATORY RODENTS
- Comments from the Behavioral Teratology Committee of the Japanese Teratology Society on OECD Guideline for the Testing of Chemicals, Proposal for a New Guideline 426, Developmental Neurotoxicity Study, Draft Document (September 2003)
- Collaborative work on evaluation of ovarian toxicity : 12) Effects of 2- or 4-week repeated dose studies and fertility study of indomethacin in female rats
- REPRODUCTIVE TOXICITY MUTAGENICITY AND ANTIGENICITY OF PAMITFLPLASE (GENETICAL RECOMBINATION)
- ESTRADIOL-INDUCED DIFFERENTIATION AND PROLIFERATION OF EPITHELIAL CELLS IN THE NEONATAL RAT OVIDUCT(Endocrinology,Abstracts of papers presented at the 74^ Annual Meeting of the Zoological Society of Japan)
- Comments from the Behavioral Teratology Committee of the Japanese Teratology Society on OECD Guideline for the Testing of Chemicals, Proposal for a New Guideline 426, Developmental Neurotoxicity Study, Draft Document (September 2003)
- Cranial anomaly of homozygous rSey rat is associated with a defect in the migration pathway of midbrain crest cells
- PHENYTOIN STIMULATES CHONDROGENIC DIFFERENTIATION IN MOUSE CLONAL CHONDROGENIC EC CELLS, ATDC5
- P6-27 Identification of genes correlated to the teratogenicity of valproic acid in mice(LIVER AND DIGESTIVE SYSTEM/CIRCULATORY SYSTEM-1/DEVELOPMENT AND REPRODUCTION)(GENERAL SESSION BY POSTER PRESENTATION)(Proceedings of the 31st Annual Meeting)
- Localization of Endothelin Receptor Subtype-A in the Testis of Rats, Dogs, and Monkeys